Browsing by Subject "Fingolimod"
Now showing items 1-1 of 1
-
Safety and tolerability of Fingolimod in Latin american patients with relapsing-remitting multiple sclerosis: the open-label FIRST LATAM study.
(Springer Naure, 2015-07)Acceso abiertoIntroduction: Fingolimod 0.5 mg is an orally active sphingosine 1-phosphate receptor modulator approved for use in adults with relapsing multiple sclerosis (MS). The efficacy and safety profile of fingolimod has been well ...